Authors: Smith, SL Pruitt, CA Sine, CS Hudgins, AC Stewart, WC

Citation: Sl. Smith et al., Latanoprost 0.005% and anterior segment uveitis, ACT OPHTH S, 77(6), 1999, pp. 668-672

Authors: Smith, SL Pruitt, CA Sine, CS Hudgins, AC Stewart, WC

Citation: Sl. Smith et al., The use of latanoprost 0.005% once daily to simplify medical therapy in patients with primary open-angle glaucoma or ocular hypertension, ACT OPHTH S, 77(2), 1999, pp. 189-192

Authors: Stewart, WC Hudgins, AC Pruitt, CA Sine, C

Citation: Wc. Stewart et al., Daily cost of newer glaucoma agents, J OCUL PH T, 15(5), 1999, pp. 379-388

Authors: Konstas, AGP Maltezos, AC Gandi, S Hudgins, AC Stewart, WC

Citation: Agp. Konstas et al., Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma, AM J OPHTH, 128(1), 1999, pp. 15-20

Authors: Stewart, WC Dubiner, HB Mundorf, TK Laibovitz, RA Sall, KN Katz, LJ Singh, K Shulman, DG Siegel, LI Hudgins, AC Nussbaum, L Apostolaros, M

Citation: Wc. Stewart et al., Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma, AM J OPHTH, 127(2), 1999, pp. 142-147